Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11065209 Use of cannabidiol in the treatment of epilepsy
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
January 12, 2021
Date of Patent
July 20, 2021
Patent Application Number
17147005
Patent Citations
US Patent 10092525 Use of cannabinoids in the treatment of epilepsy
US Patent 10918608 Use of cannabidiol in the treatment of epilepsy
US Patent 10137095 Use of cannabinoids in the treatment of epilepsy
US Patent 10111840 Use of cannabinoids in the treatment of epilepsy
Patent Citations Received
US Patent 12121617 Transdermal delivery of cannabidiol
0
US Patent 12023346 Compositions and methods for treating epilepsy
0
US Patent 12102619 Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
0
US Patent 11590087 Cannabidiol-type cannabinoid compound
US Patent 11633369 Use of cannabinoids in the treatment of epilepsy
0
US Patent 11684598 Use of cannabinoids in the treatment of epilepsy
0
US Patent 11701330 Use of cannabinoids in the treatment of epilepsy
0
US Patent 11766411 Use of cannabinoids in the treatment of epilepsy
US Patent 11400055 Use of cannabidiol in the treatment of epilepsy
US Patent 11406623 Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
•••
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11065209
Patent Primary Examiner
Craig D Ricci
Find more entities like US Patent 11065209 Use of cannabidiol in the treatment of epilepsy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE